Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?
<p>Physicians employed in operating and emergency rooms have utilized opioid antagonist for almost half a century for the treatment of opioid overdose. The prototype antagonist remainsnaloxone hydrochloride, which actually received FDA approval back in 1971. Why after so many years on the mark...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Livro |
Publicado em: |
Global Journal of Anesthesiology - Peertechz Publications,
2014-08-13.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | peertech__10_17352_2455-3476_000002 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Adam M Kaye |e author |
245 | 0 | 0 | |a Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists? |
260 | |b Global Journal of Anesthesiology - Peertechz Publications, |c 2014-08-13. | ||
520 | |a <p>Physicians employed in operating and emergency rooms have utilized opioid antagonist for almost half a century for the treatment of opioid overdose. The prototype antagonist remainsnaloxone hydrochloride, which actually received FDA approval back in 1971. Why after so many years on the market is this medication now being formulated in the form of an easy to use "auto-injector" that was designed for non-medical professionals to be able to utilize at a moment's notice? Could this wonder product, being hailed as the best possible safety tool available for life threatening opioid emergencies actual make hero's out of lay people? [1]. </p> | ||
540 | |a Copyright © Adam M Kaye et al. | ||
546 | |a en | ||
655 | 7 | |a Commentary |2 local | |
856 | 4 | 1 | |u https://doi.org/10.17352/2455-3476.000002 |z Connect to this object online. |